Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Pilot Study Awards in ovarian cancer research

Rivkin Center for Ovarian Cancer

The Rivkin Center is announcing funds for Pilot Study Awards to be allocated based on scientific merit. Pilot Study Awards support investigatorinitiated projects in all areas of ovarian cancer research. In addition, projects designed to analyze data from already funded clinical trials will be considered. The two-year awards will provide a total of $75,000 in funding. Funds are for direct costs only; institutional overhead and indirect costs will not be included in the award.

Applicants may budget for salary support, materials, supplies, consumables, travel costs for scientific meetings, and other expenses as justified. Budget and budget justification must be included with the application.

Funding priority will be given to proposals that are:

▪ Innovative

▪ Multidisciplinary

▪ Likely leading to submission of grant applications for independently funded investigations

▪ Conveying translational research potential

Requirements upon funding

Interim scientific and financial reports must be provided within 30 days following the first anniversary of the start date of the award. Final scientific and financial reports must be provided within 90 days after the completion of the funding period. In addition to submitting all final reports and annual updates, award recipients are highly encouraged to present at the next forthcoming Rivkin Center-AACR Symposium following the completion of funding. Award recipients are encouraged to use results to publish findings and develop full-scale funding applications to national agencies.

Application Format and Instructions

Applicants should submit a proposal application to the Rivkin Center via proposalcentral.com, including applicant/PI and institution contact information, scientific proposal, budget information, biosketch, other support, organizational assurances, and scientific and lay abstracts.

Scientific Proposal

The Scientific Proposal should be no more than five pages in length addressing each of the following areas: Specific Aims, Background and Significance, Preliminary Results (if available), and Research Design and Methods (Arial or other acceptable font, 11 point minimum, 8.5” x 11” paper, 0.5” margins). All tables, figures, and images must fit within the fivepage limit and be legible. References should be included and are not counted as part of the five-page limit. Additional materials (e.g. published papers, submitted manuscripts, letters of support, summary of facilities and resources, etc.) will not be considered.

Application Submission

All application materials should be submitted through proposalcentral.com by the application due date (December 2, 2024, 2 PM Pacific Time/ 5 PM Eastern Time). Applicants who do not already have an account in proposalCENTRAL must register for an account prior to beginning application. Once completed, the application must be validated to ensure all materials have been submitted. Signature pages must include a wet signature or a secure digital signature from the authorized institutional official.

More Information

Visit proposalcentral.com or rivkin.org for the latest Guidelines. Questions may be directed to Jackie Lang, PhD at Jackie.Lang@rivkin.org or (206) 584-2357.

Specialties

Gynecology

Oncology

Healthcare Delivery

Women's Health

Eligibility Requirements

Investigators at the assistant, associate, or full professor level (or equivalent) are eligible to apply, subject to guidelines of the applicant’s home institution.

Sponsor Details

Sponsor Institute/Organizations: Rivkin Center for Ovarian Cancer

Address: (206) 490-0847 1200 12th Ave S, Suite 1110, Seattle, WA 98144 info@rivkin.org

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity